BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 23298805)

  • 1. The head, neck, and systemic manifestations of levamisole-adulterated cocaine use.
    Magliocca KR; Coker NA; Parker SR
    J Oral Maxillofac Surg; 2013 Mar; 71(3):487-92. PubMed ID: 23298805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Levamisole in cocaine: unexpected news from an old acquaintance.
    Larocque A; Hoffman RS
    Clin Toxicol (Phila); 2012 Apr; 50(4):231-41. PubMed ID: 22455354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vasculopathy, hematological, and immune abnormalities associated with levamisole-contaminated cocaine use.
    Khan TA; Cuchacovich R; Espinoza LR; Lata S; Patel NJ; Garcia-Valladares I; Salassi MM; Sanders CV
    Semin Arthritis Rheum; 2011 Dec; 41(3):445-54. PubMed ID: 22152487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Agranulocytosis and other consequences due to use of illicit cocaine contaminated with levamisole.
    Buchanan JA; Lavonas EJ
    Curr Opin Hematol; 2012 Jan; 19(1):27-31. PubMed ID: 22143075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristic purpura of the ears, vasculitis, and neutropenia--a potential public health epidemic associated with levamisole-adulterated cocaine.
    Chung C; Tumeh PC; Birnbaum R; Tan BH; Sharp L; McCoy E; Mercurio MG; Craft N
    J Am Acad Dermatol; 2011 Oct; 65(4):722-725.e2. PubMed ID: 21658797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Levamisole induced necrosis of the skin and neutropenia following intranasal cocaine use: a newly recognized syndrome.
    Mouzakis J; Somboonwit C; Lakshmi S; Rumbak M; Sinnott J; Cherpelis B; Keshishian J
    J Drugs Dermatol; 2011 Oct; 10(10):1204-7. PubMed ID: 21968674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purpura, cutaneous necrosis, and antineutrophil cytoplasmic antibodies associated with levamisole-adulterated cocaine.
    Graf J; Lynch K; Yeh CL; Tarter L; Richman N; Nguyen T; Kral A; Dominy S; Imboden J
    Arthritis Rheum; 2011 Dec; 63(12):3998-4001. PubMed ID: 22127712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A warning about agranulocytosis with the use of cocaine adulterated with levamisole.
    Perkisas S; Vrelust I; Martin M; Gadisseur A; Schroyens W
    Acta Clin Belg; 2011; 66(3):226-7. PubMed ID: 21837934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Profile of Levamisole-Adulterated Cocaine-Induced Vasculitis/Vasculopathy: A 30-Case Series.
    Muñoz-Vahos CH; Herrera-Uribe S; Arbeláez-Cortés Á; Jaramillo-Arroyave D; González-Naranjo LA; Vásquez-Duque G; Restrepo-Escobar M; Correa-Londoño LA; Arias-Restrepo LF; Vanegas-García AL
    J Clin Rheumatol; 2019 Apr; 25(3):e16-e26. PubMed ID: 29782427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complications associated with use of levamisole-contaminated cocaine: an emerging public health challenge.
    Lee KC; Ladizinski B; Federman DG
    Mayo Clin Proc; 2012 Jun; 87(6):581-6. PubMed ID: 22677078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retiform purpura: a new stigmata of illicit drug use?
    Geller L; Whang TB; Mercer SE; Phelps R
    Dermatol Online J; 2011 Feb; 17(2):7. PubMed ID: 21382290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Levamisole-adulterated in cocaine causing agranulocytosis, vasculopathy, and acquired protein S deficiency.
    Dy I; Pokuri V; Olichney J; Wiernik P
    Ann Hematol; 2012 Mar; 91(3):477-8. PubMed ID: 21773730
    [No Abstract]   [Full Text] [Related]  

  • 13. Dermatologic complications from levamisole-contaminated cocaine: a case report and review of the literature.
    Gaertner EM; Switlyk SA
    Cutis; 2014 Feb; 93(2):102-6. PubMed ID: 24605347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cocaine trail: levamisole-induced leukocytoclastic vasculitis in a cocaine user.
    Metwally O; Hamidi M; Townsend L; Abualula H; Zaitoun A; Lall T
    Subst Abus; 2013; 34(1):75-7. PubMed ID: 23327508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Agranulocytosis induced by levamisole in association to cocaine].
    Pellegrini D; Young P; Grosso V; Massa M; Bruetman JE
    Medicina (B Aires); 2013; 73(5):464-6. PubMed ID: 24152407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Agranulocytosis from levamisole-adulterated cocaine.
    Caldwell KB; Graham OZ; Arnold JJ
    J Am Board Fam Med; 2012; 25(4):528-30. PubMed ID: 22773721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retiform purpura in a patient with a history of cocaine use.
    Fthenakis A; Klein PA
    Dermatol Online J; 2011 Apr; 17(4):12. PubMed ID: 21549087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Five consecutive cases of a cutaneous vasculopathy in users of levamisole-adulterated cocaine.
    Ullrich K; Koval R; Koval E; Bapoje S; Hirsh JM
    J Clin Rheumatol; 2011 Jun; 17(4):193-6. PubMed ID: 21617558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Images in clinical medicine. Toxic effects of levamisole in a cocaine user.
    Muirhead TT; Eide MJ
    N Engl J Med; 2011 Jun; 364(24):e52. PubMed ID: 21675882
    [No Abstract]   [Full Text] [Related]  

  • 20. Systemic complications of levamisole toxicity.
    Lee KC; Ladizinski B; Nutan FN
    J Am Acad Dermatol; 2012 Oct; 67(4):791-2. PubMed ID: 22980252
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.